Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 28, 2011; 17(32): 3709-3715
Published online Aug 28, 2011. doi: 10.3748/wjg.v17.i32.3709
Published online Aug 28, 2011. doi: 10.3748/wjg.v17.i32.3709
Period A(1991-1994) | Period B(1995-2000) | P-value | |
(n = 93) | (n = 201) | ||
Clinical factors | |||
Gender (male/female) | 81/12 | 161/40 | 0.144 |
Age (yr)1 | 61 ± 9 | 62 ± 9 | 0.102 |
HBs-Ag (±) | 73/20 | 169/32 | 0.243 |
Anti-HCV Ab (±/unknown) | 29/62/2 | 71/125/5 | 0.471 |
Child-Pugh classification (A/B) | 79/14 | 160/41 | 0.275 |
Preoperative Hb (g/dL)1 | 13.6 ± 1.5 | 13.3 ± 1.6 | 0.213 |
Tumor-related factors | |||
Number of tumors (single/multiple) | 70/23 | 146/55 | 0.635 |
Maximum tumor size (cm)1 | 3.8 ± 2.7 | 4.1 ± 3.1 | 0.450 |
Vascular invasion (±) | 83/10 | 172/29 | 0.388 |
Histological grade (I, II/III, IV/unknown) | 40/41/12 | 89/92/20 | 0.975 |
Surgery-related factors | |||
Procedure (nonanatomical/anatomical) | 45/48 | 101/100 | 0.767 |
Operation time (min)1 | 291 ± 144 | 295 ± 151 | 0.853 |
Resected liver volume (g)1 | 218 ± 406 | 214 ± 289 | 0.925 |
Intraoperative blood loss (mL)1 | 2190 ± 5689 | 1621 ± 2209 | 0.219 |
- Citation: Tomimaru Y, Eguchi H, Marubashi S, Wada H, Kobayashi S, Tanemura M, Umeshita K, Doki Y, Mori M, Nagano H. Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma. World J Gastroenterol 2011; 17(32): 3709-3715
- URL: https://www.wjgnet.com/1007-9327/full/v17/i32/3709.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i32.3709